Why Piper Jaffray Is Upgrading Acadia Pharmaceuticals After A 25% Decline
August 27, 2015 at 15:06 PM EDT
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares are down by more than 25 percent since July 27 as compared to a 10.5 percent ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.